|
|
Article: Research reports from Sir Charles Gairdner Hospital, Department of Haematology provide new insights into gene therapy.
- Article from:
- Gene Therapy Weekly
- Article date:
- October 23, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
New investigation results, 'Chronic myeloid leukaemia: the evolution of gene-targeted therapy,' are detailed in a study published in Medical Journal of Australia. According to a study from Perth, Australia, "Chronic myeloid leukaemia (CML) was the first human cancer linked to an acquired chromosomal abnormality, subsequently shown to be a reciprocal translocation between chromosomes 9 and 22. The resulting fusion gene product, BCR-ABL, was shown to be the causative agent of the disease."
"CML has an incidence of around 1-2 cases per 100,000; in Australia, there are probably more than 200 new cases per year and more than 1300 prevalent cases. Treatment of CML with ...
Related newspaper, magazine, and journal articles:
|
|
Article: University of Melbourne, Department of Orthopaedics publishes ...
Health & Medicine Week;
May 19, 2008 ;
700+ words
...Research findings, 'Gene therapy for osteosarcoma: steps ... According to a study from Australia, "Gene therapy, an applied form of biotechnology ... England. Keywords: Australia, Biotechnology, Cancer Gene Therapy, Chemotherapy, Clinical ...
|
|